For its fourth fiscal quarter (ending December 31), Chemed Corp (NYSE: CHE) has reported a 21% increase in E.P.S. from $3.39 a year ago to $4.09 in the current quarter. This result was in line with the consensus estimate of $4.09. For the latest four quarters through December 31, E.P.S. were $13.77 compared to $12.80 a year ago — an increase of 8%.
Recent Price Action
Chemed Corp (NYSE: CHE) stock declined slightly by -0.02% on 2/18/20. The stock closed at $491.58. Moreover, unusually high trading volume at 184% of normal accompanied the decline. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 1.4% during the last week.
Current PriceTarget Research Rating
CHE’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Chemed has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Chemed has a slightly negative Appreciation Score of 36 but a very high Power Rating of 95, leading to the Positive Value Trend Rating.
In light of this encouraging new earnings information we are reviewing our current Overall Rating of B. This review will be completed in the next several days.